---
title: "Key facts: Novo Nordisk early −21.6% 64w; Rexall delivery Canada"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286343869.md"
description: "Novo Nordisk (NOVO_B): oral Wegovy trial ECO2026/OASIS4 — early responders (≈33%) lost 13.2% at 4 months, 21.6% at 64 weeks; overall treatment 17% vs placebo 2.7%.12Novo Nordisk (NOVO_B) and Rexall partner to deliver Ozempic and Wegovy to Canadian patients' homes, offering home delivery, in-store pricing and patient support—key operational updates for traders.3"
datetime: "2026-05-14T02:06:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286343869.md)
  - [en](https://longbridge.com/en/news/286343869.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286343869.md)
---

# Key facts: Novo Nordisk early −21.6% 64w; Rexall delivery Canada

-   Novo Nordisk (NOVO\_B): oral Wegovy trial ECO2026/OASIS4 — early responders (≈33%) lost 13.2% at 4 months, 21.6% at 64 weeks; overall treatment 17% vs placebo 2.7%.12
-   Novo Nordisk (NOVO\_B) and Rexall partner to deliver Ozempic and Wegovy to Canadian patients' homes, offering home delivery, in-store pricing and patient support—key operational updates for traders.3

### Related Stocks

- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)

## Related News & Research

- [Novo Nordisk Highlights New Wegovy Pill Data](https://longbridge.com/en/news/286293294.md)
- [Novo Nordisk Says Higher-Dose Wegovy Shot Helps Some Patients Lose 28% of Their Weight](https://longbridge.com/en/news/286050253.md)
- [Novo Nordisk Presents New Wegovy Data Showing Strong Weight Loss, Fat Reduction](https://longbridge.com/en/news/286138025.md)
- [Novo’s CEO champions “record-breaking start” for Wegovy pill in US market](https://longbridge.com/en/news/285719519.md)
- [Key facts: Novo cuts India GLP-1 prices; Wegovy 3,071, Foundayo 1,390](https://longbridge.com/en/news/285790013.md)